On the basis of these assumptions, we tested two ratios between the epithelial and mesenchymal specific splicing factors, ESRP1/RBFOX2 and ESRP2/RBFOX2 in an early breast cancer setting. This evidence concerns the gene ESRP1 and breast carcinoma.